COVID-19 UPDATES AS ON 16.3.2021

 

Ministry of Health and Family Welfare

India scales several peaks in its fight against COVID19

Over 3.29crore Vaccine Doses administered across the country

Highest coverage in a Single Day with over 3 million vaccinations yesterday

More than 1 crore beneficiaries aged over 60 years covered in just 15 days

Posted On: 16 MAR 2021 11:23AM by PIB Delhi

 

In its collaborative fight against the COVID19 pandemic, Indiahas scaled several peaks today.  In a significant development, the total vaccination coverage in Indiahas crossed the3.29 crore.

Yesterday, Indiaalso recorded the highest vaccinations in a day with over 3 million vaccine doses administered.

The coverage of beneficiaries aged over 60 years has crossed 1 crore in just 15 days.

3,29,47,432vaccine doses have been administered through 5,55,984 sessions, as per the provisional report till 7 am today. These include 74,46,983HCWs (1st dose), 44,58,616HCWs (2nd dose), 74,74,406FLWs (1st dose) and 14,09,332 FLWs (2nd Dose), 18,88,727beneficiaries aged more than 45 years with specific co-morbidities (1st Dose) and 1,02,69,368beneficiaries aged more than 60 years.

 

HCWs

FLWs

45 to <60 years with Co-morbidities

Over 60 years

 

Total

1st Dose

2nd Dose

1st Dose

2nd Dose

1st Dose

1st Dose

74,46,983

44,58,616

74,74,406

14,09,332

18,88,727

1,02,69,368

3,29,47,432

 

As on Day-59 of the vaccination drive (15th March, 2021), total 30,39,394vaccine doses were given. Out of which, 26,27,099beneficiaries were vaccinated across 42,919 sessions for 1st dose (HCWs and FLWs) and 4,12,295 HCWs and FLWs received 2nd dose of vaccine.

 

Date:15th March,2021

HCWs

FLWs

45to<60 yearswithCo-morbidities

Over60years

Total Achievement

1stDose

2ndDose

1stDose

2nd Dose

1stDose

1stDose

1stDose

2ndDose

91,228

1,53,498

1,33,983

2,58,797

4,24,713

19,77,175

26,27,099

4,12,295

 

Five States,Maharashtra, Punjab, Karnataka, Gujaratand Tamil Nadu, continue to report a surge in the COVID daily new cases. 79.73% of the new cases are reported from these states in the past 24 hours.

24,492new cases were registered in the last 24 hours.

Maharashtra has reported the highest daily new cases at 15,051. It is followed by Punjabwith 1,818 while Kerala reported 1,054 new cases. 

Eight states are displaying an upward trajectory in daily new cases. These are Maharashtra, Tamil Nadu, Punjab, Madhya Pradesh, Delhi, Gujarat, Karnataka and Haryana.

Kerala is reporting a consistently declining trend over the last one month. 

India’s total Active Caseload has reached 2,23,432 today. India’s present active caseload now stands at 1.96% of India’s total Positive Cases.

Maharashtra, Kerala and Punjab cumulatively account for 76.57% of India’s total active cases. 

Total tests conducted in the country has surpassed 22.8 Cr (22,82,80,763). The cumulative national Positivity Rate currently stands at 5%.

131 deaths were reported in the last 24 hours.

Seven States account for 82.44%of the new deaths. Maharashtra saw the maximum casualties (48). Punjab follows with 27 daily deaths and Kerala reported11 deaths in the last 24 hours. 

SixteenStates/UTs have not reported any COVID19 deaths in the last 24 hours. These are Rajasthan, Chandigarh, J&K (UT), Odisha, Jharkhand, Lakshadweep, Sikkim, Ladakh (UT), D&D & D&N, Meghalaya, Manipur, Tripura, Nagaland, Mizoram, A&N Islands and Arunachal Pradesh.

 

****

MV/SJ
HFW/COVID States data/16
thMarch2021/1



(Release ID: 1705043) Visitor Counter : 416

Ministry of Health and Family Welfare

Sale of Generic Drugs in the country

Posted On: 16 MAR 2021 1:26PM by PIB Delhi

 

‘PradhanMantriBhartiyaJanaushadhiPariyojana’ (PMBJP) was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India under which quality generic medicines are sold across the country through dedicated outlets PradhanMantriBharityaJanaushadhi Kendra (PMBJK). As on 10.03.2021, 7507 PMBJKs has been opened across the country.

There is no definition of generic or branded medicines under the Drugs & Cosmetics Act, 1940 and Rules, 1945 made thereunder. However, generic medicines are generally those which contain same amount of same active ingredient(s) in same dosage form and are intended to be administered by the same route of administration as that of branded medicine. Further, drugs manufactured in the country, irrespective of whether they are generic or branded, are required to comply with the same standards as prescribed in the Drugs and Cosmetics Act, 1940 and Rules, 1945 made thereunder for their quality. As such they are expected to have similar effects.

The price of an unbranded generic version of a medicine is generally lower than the price of a corresponding branded medicine because in case of generic version, the pharmaceutical company does not spend money on promotion of its brand. The sale of a generic version is incentivized by a pharmaceutical company by keeping a high trade margin for wholesalers and retailers.

However, Clause 1.5 of Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 prescribes that every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/she shall ensure that there is a rational prescription and use of drug. Further, the erstwhile Medical Council of India had issued Circular dated 21.04.2017 vide which all the Registered Medical Practitioners (RMPs) have been directed to comply with the aforesaid provisions. The MCI or the appropriate State Medical Councils have been empowered to take disciplinary action against a doctor for violation of the provision of the aforesaid Regulations. As and when complaints are received against the violation of code of ethics for doctors, such complaints are referred by MCI to the concerned State Medical Councils where the doctors/medical practitioners are registered. Further, even Tele-Medicine Guidelines 2020; notified on 22nd May, 2020, do direct all the RMPs to use Generic Names of the drugs in capital letters on the prescription format as appended with the document.

Further, the Ministry of Health & Family Welfare has taken various regulatory measures to promote and ensure the quality of generic medicines. These include instructions to Licensing Authorities to grant/ renew licenses to manufacture for sale or for distribution of drugs in proper/generic names only, amendment in the Drugs and Cosmetics Rules, 1945 for making it mandatory to grant license for a drug formulation containing single active ingredient in proper name only, and inclusion of provision in the Rules, 1945 for submission of the result of bioequivalence study alongwith application for grant of manufacturing license in the case of certain drugs and also provision for joint inspection of manufacturing establishment by the Drugs Inspectors of Central Government and State Government.

 

Sl. No.

Name of the State/UT

Number

 

1

Andaman & Nicobar

1

2

Andhra Pradesh

178

3

Arunachal Pradesh

28

4

Assam

77

5

Bihar

222

6

Chandigarh

7

7

Chhattisgarh

229

8

Delhi

291

9

Goa

9

10

Gujarat

508

11

Haryana

200

12

Himachal Pradesh

58

13

Jammu And Kashmir

90

14

Jharkhand

70

15

Karnataka

868

16

Kerala

744

17

Ladakh

3

18

Lakshadweep*

0

19

Madhya Pradesh

216

20

Maharashtra

566

21

Manipur

32

22

Meghalaya

14

23

Mizoram

22

24

Nagaland

15

25

Odisha

267

26

Puducherry

16

27

Punjab

275

28

Rajasthan

114

29

Sikkim

3

30

Tamil Nadu

773

31

Telangana

141

32

The Dadra And Nagar Haveli And Daman And Diu

31

33

Tripura

24

34

Uttar Pradesh

1058

35

Uttarakhand

201

36

West Bengal

156

 

Grand Total

7507

*Medicines are directly supplied to the administration of

UT of Lakshwadeep

 

The Minister of State (Health and Family Welfare), Sh. Ashwini Kumar Choubey stated this in a written reply in the RajyaSabha here today.

 

*****

MV/SJ



(Release ID: 1705065) Visitor Counter : 123

Ministry of Health and Family Welfare

Demand for Indian COVID-19 Vaccines

Posted On: 16 MAR 2021 1:25PM by PIB Delhi

 

Ministry of External Affairs has received several requests for the supply of Indian manufactured COVID-19 vaccines from various foreign countries.

In its Press Release of 19 January 2021, Ministry of External Affairs had stated that "Immunization programme is being implemented in India, as in other countries, in a phased manner to cover the healthcare providers, frontline workers and the most vulnerable. Keeping in view the domestic requirements of the phased rollout, India will continue to supply COVID-19 vaccines to partner countries over the coming weeks and months in a phased manner. It will be ensured that domestic manufacturers will have adequate stocks to meet domestic requirements while supplying abroad.”

 

    S.No

Country

Total Supplies so far (in Lakhs)

  1.  

Bangladesh

90

  1.  

Myanmar

37

  1.  

Nepal

23.48

  1.  

Bhutan

1.5

  1.  

Maldives

2.12

  1.  

Mauritius

2

  1.  

Seychelles

0.5

  1.  

Sri Lanka

12.64

  1.  

Bahrain

1

  1.  

Brazil

40

  1.  

Morocoo

70

  1.  

Oman

1

  1.  

Egypt

0.5

  1.  

Algeria

0.5

  1.  

South Africa

10

  1.  

Kuwait

2

  1.  

UAE

2

  1.  

Afghanistan

9.68

  1.  

Barbados

1

  1.  

Dominica

0.7

  1.  

Mexico

8.7

  1.  

Dominican Republic

0.5

  1.  

Saudi Arabia

30

  1.  

El Salvador

0.2

  1.  

Argentina

5.8

  1.  

Serbia

1.5

  1.  

UN Health workers

1

  1.  

Mongolia

1.5

  1.  

Ukraine

5

  1.  

Ghana

6.52

  1.  

Ivory Coast

5.54

  1.  

St. Lucia

0.25

  1.  

St. Kitts & Nevis

0.2

  1.  

St. Vincent & Grenadines

0.4

  1.  

Suriname

0.5

  1.  

Antigua & Barbuda

0.4

  1.  

DR Congo

17.66

  1.  

Angola

6.24

  1.  

Gambia

0.36

  1.  

Nigeria

39.24

  1.  

Cambodia

3.24

  1.  

Kenya

11.2

  1.  

Lesotho

0.36

  1.  

Rwanda

2.9

  1.  

Sao Tome & Principe

0.24

  1.  

Senegal

3.49

  1.  

Guatemala

2

  1.  

Canada

5

  1.  

Mali

3.96

  1.  

Sudan

8.28

  1.  

Liberia

0.96

  1.  

Malawi

3.6

  1.  

Uganda

9.64

  1.  

Nicaragua

2.00

  1.  

Guyana

0.8

  1.  

Jamaica

0.50

  1.  

UK

50.00

  1.  

Togo

1.56

  1.  

Djibouti

0.24

  1.  

Somalia

3.00

  1.  

Seirra Leone

0.96

  1.  

Belize

0.25

  1.  

Botswana

0.30

  1.  

Mozambique

4.84

  1.  

Ethiopia

21.84

  1.  

Tajikistan

1.92

  1.  

Benin

1.44

  1.  

Eswatini

0.20

  1.  

Bahamas

0.20

  1.  

Cape Verde

0.24

TOTAL

583.85

 

The Minister of State (Health and Family Welfare), Sh. Ashwini Kumar Choubey stated this in a written reply in the RajyaSabha here today.

 

*****

MV/SJ



(Release ID: 1705064) Visitor Counter : 179

Ministry of Health and Family Welfare

Addressing Social Stigma associated with COVID-19 Pandemic

Posted On: 16 MAR 2021 1:24PM by PIB Delhi

 

Addressal of stigma associated with COVID-19 and resulting discrimination faced by patients as well as healthcare workers involved in COVID-19 related activities is a major theme of COVID-19 communication strategy adopted by Government of India. Ministry of Health & Family Welfare launched an anti-stigma campaign with support of key development partners. In this regard, the following steps were taken up:

 

         i.            Stigma and discrimination related messages were amplified across 12 lakh ASHAs and ANMs via pre-recorded phone messages.

        ii.            Inspirational stories on healthcare service personnel disseminated through website, DD, radio and partner agencies.

      iii.            Media, community radio, youth, volunteer and community health worker networks leveraged to take the critical message of anti-stigma.

      iv.            Several audio videos, informative guidebooks, and social media creatives to dispel COVID-19 related stigma were developed and uploaded on Ministry of Health & Family Welfare’s website, social media handles and amplified through State Government networks.

        v.            Ministry of Health & Family Welfare issued advisory not to affix posters or other signages outside the residences of COVID-19 positive patients.

 

In the context of COVID-19, the Epidemic Diseases (Amendment) Ordinance, 2020 was promulgated on 22nd April2020. Further this ordinance was brought before the Parliament has been passed and notified on 29th September 2020. The amendment provides for taking action as per this Act, against any individual who indulges in such social discriminatory behavior as to cause harassment of healthcare worker impacting the living or working conditions and preventing him/her from discharging their duties.

The Minister of State (Health and Family Welfare), Sh. Ashwini Kumar Choubey stated this in a written reply in the RajyaSabha here today.

 

*****

MV/SJ



(Release ID: 1705063) Visitor Counter : 79

Ministry of Health and Family Welfare

LASI Report on Elderly Population

Posted On: 16 MAR 2021 1:21PM by PIB Delhi

 

Longitudinal Aging Study of India Wave-1 has collected information on chronic conditions in elderly above 60 years of age, as given below:

Self reported prevalence of chronic conditions

S.N.

Condition

Percentage

1

Hypertension

32%

2

Stroke

2.7 %

3

Diabetes & High blood sugar

14.2 %

4

Chronic Lung Disease

8.3 %

 

National Policy for Older Person (NPOP)-1999 was formulated by MoSJ&E with the goal of ensuring well-being of older persons. There are 14 Principle Areas of Intervention are Under NPOP-1999, of which one of the principle areas of intervention is Health Care & Nutrition.

The Ministry of Health & Family Welfare had launched the “National Programme for the Health Care of Elderly” (NPHCE) during 2010-11 to address various health related problems of elderly people. The National Programme for the Health Care for the Elderly (NPHCE) is an articulation of the International and national commitments of the Government as envisaged under the UN Convention on the Rights of Persons with Disabilities (UNCRPD), National Policy on Older Persons (NPOP) adopted by the Government of India in 1999 & Section 20 of “The Maintenance and Welfare of Parents and Senior Citizens Act, 2007” dealing with provisions for medical care of Senior Citizen.

The programme is State oriented and basic thrust of the programme is to provide dedicated health care facilities to the senior citizens (>60 year of age) at various level of primary, secondary and tertiary health care.

Objectives:

·                                 To provide accessible, affordable, and high-quality long-term, comprehensive and dedicated care services to an Ageing population;

·                                 Creating a new "architecture" for Ageing; to build a framework to create an enabling environment for "a Society for all Ages";

·                                 To promote the concept of Active and Healthy Ageing;

·                                 Convergence with National Rural Health Mission, AYUSH and other line departments like Ministry of Social Justice and Empowerment

 

Package of Services:

·                                 Tertiary care services through OPD and in-door facilities, development of specialized human resource through various courses in geriatric medicine as well as research at Regional Geriatric Centersand national centre for aging.

·                                 Secondary and Primary care services at district hospitals and sub district level through geriatric clinics, investigations & rehabilitation services, domiciliary visits by the rehabilitation worker for bed-ridden elderly and counseling to family members for care of such patients and Health Education.

 

The Minister of State (Health and Family Welfare), Sh. Ashwini Kumar Choubey stated this in a written reply in the RajyaSabha here today.

 

*****

MV/SJ



(Release ID: 1705062) Visitor Counter : 139


Comments

Popular posts from this blog

Gove confirms mandatory housebuilding targets for councils will be abolished in face of Tory rebellion – UK politics live

Kotak Mahindra Bank Recruitment 2022 Released for Graduate Candidates And Apply Online